Trial Profile
The feasibility study of accelated infliximab infusion from initial administration
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2019
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis; Crohn's disease; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis; Ulcerative colitis
- Focus Adverse reactions
- 08 Oct 2014 New trial record